Advanced Cell Agrees To Pay $4M Over Alleged Stock Scheme
Advanced Cell Technology Inc. on Monday agreed to pay $4.1 million to resolve allegations by the U.S. Securities and Exchange Commission that the biotechnology firm issued unregistered penny stocks through sham...To view the full article, register now.
Already a subscriber? Click here to view full article